obesity, Neuroinflammation, Alzheimer Disease, Visceral adipose tissue
Amyloid, PET, Cognition, Alzheimer disease, Longitudinal study
T-cell lymphoma, histone deacetylase inhibitor, angioimmunoblastic T-cell lymphoma
Optimal Rule-Based General A+B Design in Phase I Clinical Trials
Dose-limiting toxicity (DLT), general A+B, interactive R Shiny, maximum tolerated dose (MTD), target toxicity level, traditional "3+3"